• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原子吸收光谱法测定人尿中来源于抗肿瘤药物的铂。

Determination of platinum originated from antitumoral drugs in human urine by atomic absorption spectrometric methods.

机构信息

Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Departamento de Química, Rio de Janeiro, RJ, Brazil.

出版信息

Talanta. 2010 Oct 15;82(5):1647-53. doi: 10.1016/j.talanta.2010.07.029. Epub 2010 Jul 21.

DOI:10.1016/j.talanta.2010.07.029
PMID:20875558
Abstract

Cisplatin and carboplatin are the most common platinum-based drugs used in cancer treatment. Pharmacokinetic investigations, the evaluation of the body burden during the treatment, as well as baseline levels of platinum in humans have attracted great interest. Thus, accurate analytical methods for fast and easy Pt monitoring in clinical samples become necessary. In the present study atomic absorption spectrometric methods for the determination of platinum in the forms of cisplatin and carboplatin in human urine were investigated. Platinum, in these different forms, could be determined in urine, after simple sample dilution. Regarding electrothermal atomic absorption spectrometry, the optimum parameters were defined by a central composite design optimization. Multiplicative matrix effects were overcome by using a mixture of HCl and NaCl as modifier. The limit of detection (LOD) was 0.004 mgL(-1) of platinum in the original sample. For the analysis of more concentrated samples, high resolution continuous source flame atomic absorption spectrometry was also investigated. Flame conditions were optimized by a multivariate D-optimal design, using as response the sum of the analyte addition calibration slopes and their standard deviations. Matrix matched external calibration with PtCl(2) calibration solutions, was possible, and the LOD was 0.06 mgL(-1) in the original sample. The results obtained by the proposed procedures were also in good agreement with those obtained by an independent comparative procedure.

摘要

顺铂和卡铂是癌症治疗中最常用的两种铂类药物。药代动力学研究、治疗过程中人体负荷的评估以及人类体内铂的基线水平引起了极大的兴趣。因此,需要开发准确、快速、简便的分析方法来监测临床样本中的铂。本研究建立了测定人尿液中顺铂和卡铂的原子吸收光谱法。在简单稀释尿液后,可直接测定这两种不同形式的铂。对于电热原子吸收光谱法,通过中心复合设计优化来确定最佳参数。采用 HCl 和 NaCl 的混合物作为改进剂,克服了乘法基质效应。原始样品中铂的检出限(LOD)为 0.004mg/L。对于更浓缩样品的分析,还研究了高分辨率连续光源火焰原子吸收光谱法。采用多元 D-最优设计,以分析物加标校准斜率及其标准偏差之和作为响应,优化了火焰条件。可以使用 PtCl2 校准溶液进行基体匹配的外部校准,原始样品中的检出限为 0.06mg/L。所提出的程序得到的结果与独立比较程序得到的结果吻合良好。

相似文献

1
Determination of platinum originated from antitumoral drugs in human urine by atomic absorption spectrometric methods.原子吸收光谱法测定人尿中来源于抗肿瘤药物的铂。
Talanta. 2010 Oct 15;82(5):1647-53. doi: 10.1016/j.talanta.2010.07.029. Epub 2010 Jul 21.
2
Determination of platinum in urine, ultrafiltrate, and whole plasma by isotope dilution gas chromatography-mass spectrometry compared to electrothermal atomic absorption spectrometry.与电热原子吸收光谱法相比,采用同位素稀释气相色谱-质谱法测定尿液、超滤液和全血中的铂。
Anal Biochem. 1993 Apr;210(1):113-8. doi: 10.1006/abio.1993.1159.
3
Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.用于测定人血浆超滤液中顺铂、卡铂和奥沙利铂来源铂的灵敏电感耦合等离子体质谱分析法。
J Mass Spectrom. 2006 Sep;41(9):1186-94. doi: 10.1002/jms.1087.
4
Preconcentration and determination of ultra-traces of platinum in human serum using the combined electrodeposition-electrothermal atomic absorption spectroscopy (ED-ETAAS) and chemometric method.采用联合电解沉积-电热原子吸收光谱法(ED-ETAAS)和化学计量学方法预浓缩和测定人血清中超痕量的铂。
J Pharm Biomed Anal. 2010 Sep 21;53(1):58-61. doi: 10.1016/j.jpba.2010.02.023. Epub 2010 Feb 25.
5
Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry.用电热原子吸收分光光度法直接分析血浆和尿液中的铂。
Ann Clin Lab Sci. 1989 Nov-Dec;19(6):389-96.
6
Determination of platinum traces contamination by graphite furnace atomic absorption spectrometry after preconcentration by cloud point extraction.石墨炉原子吸收光谱法通过浊点萃取预富集后测定铂痕量污染。
J Hazard Mater. 2010 Apr 15;176(1-3):207-12. doi: 10.1016/j.jhazmat.2009.11.014. Epub 2009 Nov 6.
7
Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.电感耦合等离子体质谱法定量分析接受顺铂或卡铂化疗患者外周血白细胞中的铂-DNA加合物。
Clin Cancer Res. 1996 Nov;2(11):1829-35.
8
Determination of zinc in vegetal tissue microsamples by platinum-wire loop in flame atomization atomic absorption spectrometry.火焰原子化原子吸收光谱法中用铂丝环测定植物组织微量样品中的锌
J Biochem Biophys Methods. 2008 Apr 24;70(6):1234-9. doi: 10.1016/j.jbbm.2007.04.006. Epub 2007 May 8.
9
Electrothermal atomic absorption spectrometric-determination of cobalt in human serum and urine.电热原子吸收光谱法测定人血清和尿液中的钴
Acta Pharm. 2003 Jun;53(2):83-90.
10
Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry.采用电热原子吸收光谱法测定顺铂治疗后肿瘤组织中的铂含量。
J Pharm Biomed Anal. 1997 Oct;16(2):343-8. doi: 10.1016/s0731-7085(97)00045-9.

引用本文的文献

1
Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes.奥沙利铂长循环脂质体的表征和药代动力学评价。
Biomed Res Int. 2021 Apr 20;2021:5949804. doi: 10.1155/2021/5949804. eCollection 2021.
2
Influence of Digestion Procedure and Residual Carbon on Manganese, Copper, and Zinc Determination in Herbal Matrices by Atomic Absorption Spectrometry.消解程序和残留碳对采用原子吸收光谱法测定草药基质中锰、铜和锌的影响
J Anal Methods Chem. 2017;2017:6947376. doi: 10.1155/2017/6947376. Epub 2017 Oct 19.
3
Pharmacokinetics and tissue distribution of novel platinum containing anticancer agent BP-C1 studied in rabbits using sector field inductively coupled plasma mass spectrometry.
使用扇形磁场电感耦合等离子体质谱法在兔体内研究新型含铂抗癌剂BP-C1的药代动力学和组织分布。
Drug Test Anal. 2015 Sep;7(9):737-44. doi: 10.1002/dta.1824. Epub 2015 Jun 10.